lancet-header

Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.

Economic Burden of Neurological Disorders in an Aging Society, the Example of Japan: A Panel Data Analysis

10 Pages Posted: 19 Jan 2020

See all articles by Farhad Taghizadeh-Hesary

Farhad Taghizadeh-Hesary

Tokai University; Waseda University

Naoyuki Yoshino

Asian Development Bank Institute

Aline Mortha

Waseda University - Graduate School of Economics; Keio University

Farzad Taghizadeh-Hesary

Shahid Beheshti University of Medical Sciences

Farnaz Roshanmehr

Waseda University

John Fiallos

Society for Brain Mapping & Therapeutics

Erika Tajra

Society for Brain Mapping & Therapeutics

Joe Bolanos

Society for Brain Mapping & Therapeutics

Marco Amaya

Society for Brain Mapping & Therapeutics

Peyman Tashkandi

University of Southern California

Jonathan Dang

Society for Brain Mapping & Therapeutics

Babak Kateb

Society for Brain Mapping & Therapeutics

More...

Abstract

Background: This research explored the burden of two neurological diseases, Alzheimer Disease (AD) and strokes on Japanese economy. While previous studies on the topic focused on accounting costs associated with the diseases, our research explored the loss of gross domestic product (GDP) due to the reduction of the labor force, which is attributed to increased prevalence and informal care of both diseases.

Methods: Using time series panel data from Japanese prefectures between 2001 to 2012, we analyzed our study in two steps. First, we quantify the loss of GDP due to the reduction of labor force using the Cobb-Douglass production function to measure the relationship between the output (products) and labor.  Next, we analyzed the total labor loss (LT) attributed to the increase prevalence and informal care of the two diseases. Finally, we plug the estimated value of LT in Cobb-Douglass-type of production function, in order to obtain the loss in output due to the shortage of labor.

Findings: The difference between two GDPs (GDP with no labor loss and the actual GDP) is maximized in 2001, is 1.4%. However, it is interesting to note that, despite a steady increase of shortage of labor over the years, the gap between actual and predicted GDP is shrinking and in 2012 the gap is 1%. This evolution could be explained by higher values for capital and total factor productivity.  Urban prefectures such as Tokyo or Osaka tended to suffer less from a loss of GDP than rural ones, such as Aomori, Niigata or Hokkaido for instance. In addition, empirical results show that, prefectures relying heavily on tourism such as Kyoto, Nara or, to a lesser extent, Kagawa, appeared to show reduced losses due to the shortage of labor, as a consequence of AD and strokes.

Interpretation: Our study confirmed that economic costs as a result of labor loss are higher than accounting costs. The empirical analysis confirmed that the loss of labor due to AD and strokes has been increasing over the past decade. However, owing to increased investments in Research and Development (R&D) and higher private capital stock, the loss of GDP has been slightly reduced in the period of study. Nevertheless, given the trend of aging population in Japan and many other G20 economies, increasing R&D and private capital stock may not be sustainable in the future.

Funding Statement: This research was supported by JSPS Kakenhi (2019-2020) Grant-in-Aid for Young Scientists No. 19K13742 and Grant in-Aid for Excellent Young Researcher of the Ministry of Education of Japan (MEXT).

Declaration of Interests: Authors report no conflict of interest.

Ethics Approval Statement: Not required.

Keywords: Neurological Disorders; Aging Society; Economic Burden; Japan

Suggested Citation

Taghizadeh-Hesary, Farhad and Yoshino, Naoyuki and Mortha, Aline and Taghizadeh-Hesary, Farzad and Roshanmehr, Farnaz and Fiallos, John and Tajra, Erika and Bolanos, Joe and Amaya, Marco and Tashkandi, Peyman and Dang, Jonathan and Kateb, Babak, Economic Burden of Neurological Disorders in an Aging Society, the Example of Japan: A Panel Data Analysis (January 6, 2020). Available at SSRN: https://ssrn.com/abstract=3514749 or http://dx.doi.org/10.2139/ssrn.3514749

Farhad Taghizadeh-Hesary (Contact Author)

Tokai University ( email )

3-20-1 Orido
Shimizu-ku
Shizuoka, 424-8610
Japan

Waseda University ( email )

1-104 Totsukamachi, Shinjuku-ku
tokyo, 169-8050
Japan

Naoyuki Yoshino

Asian Development Bank Institute ( email )

Kasumigaseki Building 8F
3-2-5, Kasumigaseki, Chiyoda-ku
Tokyo, 100-6008
Japan

Aline Mortha

Waseda University - Graduate School of Economics

1-6-1 Nishi-waseda, Shinjuku-ku
Tokyo
Japan

Keio University

2-15-45 Mita
Minato-ku
Tokyo, 108-8345
Japan

Farzad Taghizadeh-Hesary

Shahid Beheshti University of Medical Sciences

Velenjak Street, Shahid Chamran High Way
Tehran
Iran

Farnaz Roshanmehr

Waseda University

1-104 Totsukamachi, Shinjuku-ku
tokyo, 169-8050
Japan

John Fiallos

Society for Brain Mapping & Therapeutics

CA
United States

Erika Tajra

Society for Brain Mapping & Therapeutics

CA
United States

Joe Bolanos

Society for Brain Mapping & Therapeutics

CA
United States

Marco Amaya

Society for Brain Mapping & Therapeutics

CA
United States

Peyman Tashkandi

University of Southern California

2250 Alcazar Street
Los Angeles, CA 90089
United States

Jonathan Dang

Society for Brain Mapping & Therapeutics

CA
United States

Babak Kateb

Society for Brain Mapping & Therapeutics

CA
United States